Supplementary Therapeutic Possibilities to Alleviate Myocardial Damage Due to Microvascular Dysfunction in Coronavirus Disease 2019 (COVID-19)
Author:
Funder
Servier
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
https://link.springer.com/content/pdf/10.1007/s40119-021-00216-8.pdf
Reference44 articles.
1. Pllard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol. 2021;21:83–100.
2. COVID-19 treatment Guidelines. An official website of the National Institutes of Health. http://www.covid19treatmentguidelinesnih.gov. Accessed 5 Mar 2021.
3. Klopfenstein T, Zayet S, Lohse A, Balblanc JC, Bodie J, Royer PY, et al. Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients. Med Mal Infect. 2020;50:397–400.
4. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, de Castilla DL, Finberg RW, et al. Remdesivir for the treatment of Covid-19 — final report. N Engl J Med. 2020;2020(383):1813–26. https://doi.org/10.1056/NEJMoa2007764.
5. Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097–100. https://doi.org/10.1093/cvr/cvaa078 (Published 30 Mar 2020).
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The use of prescription drugs and health care services during the 6-month post-COVID-19 period;Scientific Reports;2023-07-19
2. TRPM7 mediates endoplasmic reticulum stress and ferroptosis in sepsis-induced myocardial injury;Journal of Bioenergetics and Biomembranes;2023-06
3. COVID‐19 metabolism: Mechanisms and therapeutic targets;MedComm;2022-08-09
4. The Potential of Dietary Bioactive Compounds against SARS-CoV-2 and COVID-19-Induced Endothelial Dysfunction;Molecules;2022-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3